OBJECTIVES/HYPOTHESIS: Vocal fold scar and sulcus are still challenges. Basic fibroblast growth factor (bFGF) has proven to be effective to resolve scar tissue in animal models. This study reports the efficacy of regenerative treatments using bFGF on vocal fold scar and sulcus in human cases. STUDY DESIGN: Retrospective chart review. METHODS: Fifteen cases (7 scar; 8 sulcus) were treated by either local injection of bFGF (n = 6) or regenerative surgery using bFGF (n = 9). Injection regimen was to locally apply 10 micrograms of bFGF in 0.5 mL saline into each vocal fold under topical anesthesia repeatedly (4 times with intervals of 1 week between each injection). The regenerative surgical procedure consisted of the dissection of scar tissue and the implant of gelatin sponge with bFGF. Follow-up periods ranged from 6 months to 24 months. RESULTS: Maximum Phonation Time (MPT); Voice Handicap Index (VHI)-10; and Grade, Roughness, Breathiness, Asthenia, Strain (GRBAS) scale were assessed in both groups. The injection group showed significant improvement on VHI-10 and GRBAS. The regenerative surgery group showed significant improvement in all parameters. Jitter and shimmer were evaluated in the surgery group, and the results indicated improvement in six and five cases of nine cases, respectively. No major adverse effects were observed in both treatment groups. CONCLUSIONS: Regenerative treatments using bFGF has shown to be effective for improvement of vocal function in scar and sulcus.
OBJECTIVES/HYPOTHESIS: Vocal fold scar and sulcus are still challenges. Basic fibroblast growth factor (bFGF) has proven to be effective to resolve scar tissue in animal models. This study reports the efficacy of regenerative treatments using bFGF on vocal fold scar and sulcus in human cases. STUDY DESIGN: Retrospective chart review. METHODS: Fifteen cases (7 scar; 8 sulcus) were treated by either local injection of bFGF (n = 6) or regenerative surgery using bFGF (n = 9). Injection regimen was to locally apply 10 micrograms of bFGF in 0.5 mL saline into each vocal fold under topical anesthesia repeatedly (4 times with intervals of 1 week between each injection). The regenerative surgical procedure consisted of the dissection of scar tissue and the implant of gelatin sponge with bFGF. Follow-up periods ranged from 6 months to 24 months. RESULTS: Maximum Phonation Time (MPT); Voice Handicap Index (VHI)-10; and Grade, Roughness, Breathiness, Asthenia, Strain (GRBAS) scale were assessed in both groups. The injection group showed significant improvement on VHI-10 and GRBAS. The regenerative surgery group showed significant improvement in all parameters. Jitter and shimmer were evaluated in the surgery group, and the results indicated improvement in six and five cases of nine cases, respectively. No major adverse effects were observed in both treatment groups. CONCLUSIONS: Regenerative treatments using bFGF has shown to be effective for improvement of vocal function in scar and sulcus.
Authors: M Graupp; S Bachna-Rotter; C Gerstenberger; G Friedrich; E Fröhlich-Sorger; K Kiesler; M Gugatschka Journal: Eur Arch Otorhinolaryngol Date: 2015-06-25 Impact factor: 2.503
Authors: Yue Ma; Jennifer Long; Milan R Amin; Ryan C Branski; Edward J Damrose; Chih-Kwang Sung; Stratos Achlatis; Ann Kearney; Dinesh K Chhetri Journal: Laryngoscope Date: 2019-12-05 Impact factor: 3.325
Authors: Josh D Erndt-Marino; Andrea C Jimenez-Vergara; Patricia Diaz-Rodriguez; Jonathan Kulwatno; Juan Felipe Diaz-Quiroz; Susan Thibeault; Mariah S Hahn Journal: J Biomed Mater Res B Appl Biomater Date: 2017-06-05 Impact factor: 3.368
Authors: Jaime E Moore; Paul J Rathouz; Jeffrey A Havlena; Qianqian Zhao; Seth H Dailey; Maureen A Smith; Caprice C Greenberg; Nathan V Welham Journal: Laryngoscope Date: 2016-03-12 Impact factor: 3.325